Mcrae Capital Management Inc. decreased its stake in Xylem Inc. (NYSE:XYL) by 7.4% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,250 shares of the industrial products company’s stock after selling 500 shares during the period. Mcrae Capital Management Inc.’s holdings in Xylem were worth $346,000 as of its most recent filing with the SEC.

Several other large investors also recently added to or reduced their stakes in the company. Baldwin Brothers Inc. MA raised its stake in Xylem by 106.6% in the first quarter. Baldwin Brothers Inc. MA now owns 33,020 shares of the industrial products company’s stock valued at $1,658,000 after buying an additional 17,039 shares in the last quarter. Town & Country Bank & Trust CO dba First Bankers Trust CO raised its stake in Xylem by 1.5% in the first quarter. Town & Country Bank & Trust CO dba First Bankers Trust CO now owns 13,490 shares of the industrial products company’s stock valued at $677,000 after buying an additional 200 shares in the last quarter. Capstone Asset Management Co. raised its stake in Xylem by 2.3% in the first quarter. Capstone Asset Management Co. now owns 17,939 shares of the industrial products company’s stock valued at $901,000 after buying an additional 400 shares in the last quarter. Bank of Montreal Can raised its stake in Xylem by 29.9% in the first quarter. Bank of Montreal Can now owns 432,277 shares of the industrial products company’s stock valued at $21,709,000 after buying an additional 99,573 shares in the last quarter. Finally, Gulf International Bank UK Ltd raised its stake in Xylem by 1.9% in the first quarter. Gulf International Bank UK Ltd now owns 54,251 shares of the industrial products company’s stock valued at $2,724,000 after buying an additional 1,000 shares in the last quarter. 86.41% of the stock is owned by institutional investors and hedge funds.

Xylem Inc. (XYL) traded up 0.24% during trading on Friday, reaching $59.12. The company’s stock had a trading volume of 506,147 shares. The company has a market cap of $10.62 billion, a P/E ratio of 38.17 and a beta of 1.18. The company’s 50 day moving average price is $56.81 and its 200 day moving average price is $51.96. Xylem Inc. has a 52 week low of $45.60 and a 52 week high of $60.71.

Xylem (NYSE:XYL) last released its quarterly earnings results on Tuesday, August 1st. The industrial products company reported $0.59 EPS for the quarter, topping the Zacks’ consensus estimate of $0.57 by $0.02. Xylem had a net margin of 7.08% and a return on equity of 16.02%. The business had revenue of $1.16 billion during the quarter, compared to analysts’ expectations of $1.17 billion. During the same quarter in the previous year, the company earned $0.48 EPS. The business’s quarterly revenue was up 24.9% compared to the same quarter last year. On average, equities analysts anticipate that Xylem Inc. will post $2.37 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Mcrae Capital Management Inc. Lowers Stake in Xylem Inc. (XYL)” was originally reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are viewing this piece on another site, it was copied illegally and reposted in violation of US & international trademark and copyright legislation. The legal version of this piece can be read at https://theolympiareport.com/2017/08/12/mcrae-capital-management-inc-has-346000-position-in-xylem-inc-xyl-updated.html.

Several research firms have recently weighed in on XYL. Cowen and Company reissued an “outperform” rating and set a $70.00 price objective (up from $60.00) on shares of Xylem in a research note on Wednesday. Royal Bank Of Canada raised their target price on Xylem from $58.00 to $64.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 2nd. Oppenheimer Holdings, Inc. raised their target price on Xylem from $60.00 to $66.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 2nd. BMO Capital Markets raised their target price on Xylem from $60.00 to $65.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 2nd. Finally, Canaccord Genuity reaffirmed a “hold” rating and issued a $50.00 target price on shares of Xylem in a research report on Friday, July 28th. Five investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. The stock currently has an average rating of “Buy” and an average price target of $59.00.

In other news, Director Steven R. Loranger sold 66,132 shares of the company’s stock in a transaction on Thursday, June 29th. The shares were sold at an average price of $55.01, for a total value of $3,637,921.32. Following the completion of the sale, the director now owns 65,030 shares of the company’s stock, valued at approximately $3,577,300.30. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Kenneth Napolitano sold 9,052 shares of the company’s stock in a transaction on Wednesday, August 9th. The shares were sold at an average price of $60.16, for a total transaction of $544,568.32. Following the completion of the sale, the insider now directly owns 35,303 shares of the company’s stock, valued at approximately $2,123,828.48. The disclosure for this sale can be found here. 0.75% of the stock is currently owned by corporate insiders.

Xylem Company Profile

Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.